Evidence map›Paper›PMID 32816856›Full record

ArticleCancer research2020

Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells.

Karina E Gomez, FangLong Wu, Stephen B Keysar, J Jason Morton, Bettina Miller, Tugs-Saikhan Chimed, Phuong N Le, Cera Nieto, Farshad N Chowdhury, Anit Tyagi and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 167 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Karina E GomezDivision of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
FangLong WuDepartment of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Stephen B KeysarDivision of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
J Jason MortonDivision of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Bettina MillerDivision of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Tugs-Saikhan ChimedDivision of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Phuong N LeDivision of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Cera NietoDivision of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Farshad N ChowdhuryDivision of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Anit TyagiDivision of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0001-9455-2591
Traci R LyonsDivision of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0002-8876-0391
Christian D YoungDepartment of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0001-9846-488X
Hongmei ZhouState Key Laboratory of Oral Diseases, Department of Oral Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Hilary L SomersetDepartment of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Xiao-Jing WangDepartment of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0001-8695-7361
Antonio JimenoDivision of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado. antonio.jimeno@cuanschutz.edu.
University of Colorado Anschutz Medical Campus · USSichuan University · CNVA Eastern Colorado Health Care System · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Medical Scientist Training ProgramT32GM008497 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI WILSON, CARA C. · 1993 to 2022
$15.2M
Transgenic and Gene Targeting CoreP30AR057212 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI NORRIS, DAVID A. · 2009 to 2018
$6.2M
Targeting PD-L1 interactome signaling to enhance immunotherapy efficacy in head and neck squamous cell cancerR01CA149456 · NCI · UNIVERSITY OF COLORADO DENVER · PI Antonio Jimeno · 2010 to 2026
$5.6M
Training in Translational Research of Lung, Head and Neck CancerT32CA174648 · NCI · UNIVERSITY OF COLORADO DENVER · PI KARAM, SANA D · 2013 to 2022
$4.2M
Institutional Training in Otolaryngology ResearchT32DC012280 · NIDCD · UNIVERSITY OF COLORADO DENVER · PI Yuri Agrawal, Sue C. Kinnamon · 2013 to 2026
$3.4M
NRSA Training CoreTL1TR002533 · NCATS · UNIVERSITY OF COLORADO DENVER · PI CICUTTO, LISA · 2018 to 2022
$3.0M
Identifying oral cancer stem cell properties affected by the microenvironmentR01DE024371 · NIDCR · UNIVERSITY OF COLORADO DENVER · PI JIMENO, ANTONIO, WANG, XIAO-JING · 2014 to 2017
$2.1M
Deciphering COX-2/SEMA7A dependent mechanisms of breast tumor progression.R01CA211696 · NCI · UNIVERSITY OF COLORADO DENVER · PI LYONS, TRACI · 2017 to 2021
$2.0M
Identification of normal and cancer stem cells and their niche in oral mucosaRC1DE020649 · NIDCR · UNIVERSITY OF COLORADO DENVER · PI WANG, XIAO-JING · 2009 to 2010
$869k
Rational generation of a head and neck squamous cell cancer direct xenograft modeR21DE019712 · NIDCR · UNIVERSITY OF COLORADO DENVER · PI JIMENO, ANTONIO · 2009 to 2010
$385k
BLRD VA I01 BX003232NCATS NIH HHS TL1 TR002533NCI NIH HHS P30 CA046934NCI NIH HHS R01 CA149456NCI NIH HHS R01 CA211696NCI NIH HHS T32 CA174648NIAMS NIH HHS P30 AR057212NIDCD NIH HHS T32 DC012280NIDCR NIH HHS R01 DE024371NIDCR NIH HHS R21 DE019712NIDCR NIH HHS RC1 DE020649NIGMS NIH HHS T32 GM008497
6 · The paper itself

Abstract

Tumor-associated macrophages (TAM) in the tumor microenvironment (TME) cooperate with cancer stem cells (CSC) to maintain stemness. We recently identified cluster of differentiation 44 (CD44) as a surface marker defining head and neck squamous cell carcinoma (HNSCC) CSC. PI3K-4EBP1-SOX2 activation and signaling regulate CSC properties, yet the upstream molecular control of this pathway and the mechanisms underlying cross-talk between TAM and CSC in HNSCC remain largely unknown. Because CD44 is a molecular mediator in the TME, we propose here that TAM-influenced CD44 signaling could mediate stemness via the PI3K-4EBP1-SOX2 pathway, possibly by modulating availability of hyaluronic acid (HA), the main CD44 ligand. HNSCC IHC was used to identify TAM/CSC relationships, and

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCell Cycle ProteinsCell Line, TumorFeedback, PhysiologicalFemaleHead and Neck NeoplasmsHumansHyaluronan ReceptorsHyaluronic AcidMaleMice, Inbred NODMonocytesNeoplastic Stem CellsPhosphatidylinositol 3-KinasesSOXB1 Transcription FactorsAdaptor Proteins, Signal TransducingCD44 protein, humanCell Cycle ProteinsEIF4EBP1 protein, humanHyaluronan ReceptorsHyaluronic AcidPhosphatidylinositol 3-KinasesSOX2 protein, humanSOXB1 Transcription FactorsZEB1 protein, humanZinc Finger E-box-Binding Homeobox 1

Identifiers

PMID32816856
PMCPMC8146866
OpenAlexW3049314385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.